We are live on ! Find out more
WJA

Williams Jones & Associates Portfolio holdings

AUM $4.82B
1-Year Est. Return 19.95%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+19.95%
3 Year Est. Return
+72.11%
5 Year Est. Return
+86.19%
10 Year Est. Return
AUM
$3.24B
AUM Growth
+$1.1B
Cap. Flow
+$1.04B
Cap. Flow %
32.2%
Top 10 Hldgs %
24.95%
Holding
434
New
69
Increased
208
Reduced
78
Closed
33

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$26.1M
2
SIG icon
Signet Jewelers
SIG
+$22M
3
GT icon
Goodyear
GT
+$18M
4
BX icon
Blackstone
BX
+$9.22M
5
WSM icon
Williams-Sonoma
WSM
+$7.23M

Sector Composition

Rank Sector Weight
1 Healthcare 18.82%
2 Industrials 13.57%
3 Technology 11.96%
4 Financials 11.11%
5 Communication Services 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STT icon
376
State Street
STT
$50.5B
-3,807
Closed -$223K
SWKS icon
377
Skyworks Solutions
SWKS
$9.22B
-3,235
Closed -$252K
TEVA icon
378
Teva Pharmaceuticals
TEVA
$40.2B
-1,317
Closed -$70K
VUG icon
379
Vanguard Morningstar Growth ETF
VUG
$225B
-10,194
Closed -$181K
ISBC
380
DELISTED
Investors Bancorp, Inc.
ISBC
-25,000
Closed -$291K
TTPH
381
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
-719
Closed -$67K
CYS
382
DELISTED
CYS Investments Inc.
CYS
-9,300
Closed -$76K

Similar funds

Williams Jones & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Williams Jones & Associates held 434 positions worth $3.24B, up 51% from $2.15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Williams Jones & Associates deployed $1.04B of net new capital in Q2 2016, opening 69 new positions and adding to 208 existing holdings. Its largest new stake was Idexx Laboratories: 657,531 shares worth $61.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was CVS Health, an estimated $26.1M trimmed.

  • Williams Jones & Associates's largest Q2 2016 buy was Idexx Laboratories: 657,531 shares worth $61.1M.
  • Williams Jones & Associates added most to Visa in Q2 2016, an estimated $85M increase.
  • Williams Jones & Associates's biggest Q2 2016 reduction was CVS Health, cutting an estimated $26.1M.
  • Williams Jones & Associates fully exited Signet Jewelers in Q2 2016, selling an estimated $22M.
  • Williams Jones & Associates's ten largest holdings make up 25% of its $3.24B portfolio in Q2 2016.
  • Williams Jones & Associates opened 69 new positions and closed 33 in Q2 2016.
  • Williams Jones & Associates's portfolio value rose 51% quarter-over-quarter to $3.24B.

Based on Williams Jones & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.